Mehran Sugar Mills Limited (MRNS)
Feb 11, 2025 - MRNS was delisted (reason: acquired by Immedica)
0.5500
+0.0010 (0.09%)
Inactive · Last trade price on Feb 11, 2025
Marinus Pharmaceuticals Employees
Mehran Sugar Mills had 278 employees as of September 30, 2024. The number of employees did not change compared to the previous year.
Employees
278
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$176,846
Profits / Employee
$1,930
Market Cap
18.74M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 278 | 0 | - |
| Sep 30, 2023 | 278 | 20 | 7.75% |
| Sep 30, 2022 | 258 | -66 | -20.37% |
| Sep 30, 2021 | 324 | -5 | -1.52% |
| Sep 30, 2020 | 329 | -253 | -43.47% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
MRNS News
- 10 months ago - MARINUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Marinus Pharmaceuticals, Inc. - MRNS - Business Wire
- 11 months ago - Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc. - Business Wire
- 1 year ago - Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results - Business Wire
- 1 year ago - Marinus Pharmaceuticals Announces Topline Results From Phase 3 TrustTSC Trial of Oral Ganaxolone in Tuberous Sclerosis Complex and Commences Process to Explore Strategic Alternatives - Business Wire
- 1 year ago - Marinus Pharmaceuticals Presents Clinical Data From Pivotal Phase 3 RAISE Trial in Refractory Status Epilepticus at the Neurocritical Care Society 2024 Annual Meeting - Business Wire
- 1 year ago - 3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity - Benzinga
- 1 year ago - Marinus Pharmaceuticals Further Strengthens Intellectual Property Estate with Method of Treatment Patent for ZTALMY® Titration Regimens - Business Wire
- 1 year ago - Marinus Pharmaceuticals Announces Podium and Poster Presentations at the Neurocritical Care Society 2024 Annual Meeting - Business Wire